Journal Menu
► ▼ Journal Menu-
- Nutrients Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Early Career Editorial Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
15 May 2026
Nutrients 2026—Clinical Nutrition: From Research to Practice—Submissions Approaching & Plenary Speaker Announcement, 22–24 October 2026, Barcelona, Spain
Conference: Nutrients 2026—Clinical Nutrition: From Research to Practice
Date: 22–24 October 2026
Website: https://sciforum.net/event/Nutrients2026
We cordially invite you to attend this event organized by MDPI’s Nutrients (ISSN: 2072-6643, impact factor: 5.0, CiteScore: 9.1). It will take place from 22 to 24 October 2026 at UAB Casa Convalescencia, Barcelona, Spain.
Conference Chairs:
- Prof. Dr. Maria Luz Fernandez, University of Connecticut, USA;
- Prof. Dr. Lluis Serra Majem, University of Las Palmas de Gran Canaria, Spain;
- Dr. Francisco Jose Perez Cano, University of Barcelona, Spain.
The topics of interest:
S1. Personalized nutrition based on diet–gene interactions;
S2. Innovations in clinical nutrition;
S3. Novel dietary recommendations for specific chronic diseases;
S4. Understanding the role of microbiota in clinical practice;
S5. The potential role of AI in clinical practice;
S6. Lifestyle and prevention of chronic diseases.
Plenary speaker announcement:
We are honoured to have Dr. Carlo La Vechia, from the University of Milan (“La Statale”), Italy, as Nutrients 2026 Plenary Speaker for Session 6: Lifestyle and prevention of chronic diseases.
Other renowned researchers from internationally prestigious universities and institutes, including Yale School of Public Health, University of Connecticut, Qatar University, Icahn Medical School of Mount Sinai, and many more, are contributing with us as keynote speakers and scientific committee members.
To view all contributing researchers, please click the following links:
https://sciforum.net/event/Nutrients2026?section=#event_chairs .
Academic supporters:
Nutrients 2026 is currently supported by and partnered with esteemed universities, institutes, and societies.
To view all supporting organizations and partners, please click on the following links:
https://sciforum.net/event/Nutrients2026?section=#sup_org.
Important dates:
Deadline for abstract submissions: 24 June 2026;
Notification of acceptance: 20 July 2026;
Deadline for early bird registration: 24 July 2026;
Deadline for covering author registration: 24 July 2026.
Guide for authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1496.
To register for the event, please click on the following link: https://sciforum.net/event/Nutrients2026?section=#registration.
For details regarding abstract submission, poster and slide submission, and publication opportunities, you may refer to the “Instructions for Authors” section below: https://sciforum.net/event/Nutrients2026?section=#instructions.
For any enquiries regarding the event, please contact nutrients2026@mdpi.com.
We look forward to seeing you at Nutrients 2026.
23 July 2025
Nutrients 2026—Clinical Nutrition: From Research to Practice—Open for Submissions
Conference: Nutrients 2026—Clinical Nutrition: From Research to Practice
Date: 22–24 October 2026, CEST, Barcelona, Spain
Website: https://sciforum.net/event/Nutrients2026
We cordially invite you to attend this event organized by MDPI’s Nutrients (ISSN: 2072-6643, impact factor: 5.0, CiteScore: 9.1). It will take place on 22 to 24 October 2026, CEST, in Barcelona, Spain.
Conference Chairs:
- Prof. Dr. Maria Luz Fernandez, University of Connecticut, USA;
- Prof. Dr. Lluis Serra Majem, University of Las Palmas de Gran Canaria, Spain.
The Topics of Interest:
S1. Personalized nutrition based on diet–gene interactions;
S2. Innovations in clinical nutrition;
S3. Novel dietary recommendations for specific chronic diseases;
S4. Understanding the role of microbiota in clinical practice;
S5. The potential role of AI in clinical practice;
S6. Lifestyle and prevention of chronic diseases.
Important Dates
Deadline for abstract submissions: 24 June 2026;
Notification of acceptance: 20 July 2026;
Deadline for early bird registration: 24 July 2026;
Deadline for covering author registration: 24 July 2026.
Guide for Authors
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1496.
To register for the event, please click on the following link: https://sciforum.net/event/Nutrients2026?section=#registration.
For details regarding abstract submission, poster and slide submission, and publication opportunities, you may refer to the “Instructions for Authors” section below: https://sciforum.net/event/Nutrients2026?section=#instructions.
For any enquiries regarding the event, please contact nutrients2026@mdpi.com.
We look forward to seeing you at Nutrients 2026.
2 June 2026
Interview with Dr. Grzegorz Bartosz—Winner of the Nutrients Outstanding Reviewers Award
1. Can you briefly introduce yourself and the main content of your current research?
I graduated first in chemistry and later in physics from the University of Łódź in central Poland. For many years, I worked in the Department and later the Institute of Biophysics, where my research initially focused on aging at the cellular level. Over time, my scientific interests shifted toward reactive oxygen species and antioxidants, which remain the primary focus of my work today.
At the beginning, I worked mainly on synthetic antioxidants, especially nitroxides, but gradually my research moved more toward natural antioxidants and their mechanisms of action, as well as methods used to estimate antioxidant activity and antioxidant content.
Throughout my academic career, I also had opportunities to work internationally. I spent some time at Texas A&M University in the United States, then later in Düsseldorf, Germany, and also at Macquarie University in Australia. For a period, I worked simultaneously at the University of Łódź and at the University of Rzeszów in southeastern Poland.
Although I am now retired from the University of Łódź, I continue working at the University of Rzeszów, specifically at the Institute of Food Technology and Nutrition. At present, my research is still focused mainly on natural antioxidants and their biological actions.
2. When and how did you first become aware of Nutrients? What attracts you most about this journal?
It is actually difficult for me to remember exactly when I first became aware of Nutrients, because within the field of antioxidants and natural antioxidants, it has long been a very well-known and respected journal.
My own research often fits more closely with journals such as the International Journal of Molecular Sciences or Foods, especially because much of our work focuses on mechanisms of antioxidant action. Nevertheless, we regularly considered Nutrients as a possible publication venue, and the journal has always had a very strong reputation in our field.
In Poland, Nutrients is a highly respected journal. One important practical factor is that at our university, publication costs can be reimbursed when the journal has a sufficiently high impact factor. Since Nutrients has a strong impact factor and excellent standing in the field, it fully meets these criteria.
What attracts me most is the journal’s scientific reputation, its visibility, and the efficiency of its editorial process. It is a journal that researchers in my field recognize and respect.
3. Could you share with us your feelings about winning the award? What does this award mean to your academic career?
Winning the Reviewer Award was truly both an honor and a surprise for me. During a certain period, Nutrients kindly sent me many manuscripts for review, most of them closely related to my expertise, which made the reviewing process both interesting and intellectually rewarding.
Reviewing often required me to consult additional literature and verify details carefully. I really enjoyed being involved so actively with the journal, but I certainly did not expect such recognition.
At this stage of my life, my academic career is naturally approaching its later phase, but this award still means a lot to me professionally. Recognition of this kind strengthens appreciation within the university environment and contributes positively to one’s academic standing and reputation.
I was therefore genuinely very pleased and grateful to receive this distinction.
4. What role do you think reviewers play in the process of paper publication?
I believe the role of reviewers is extremely important. As both an author and reviewer, I have seen how peer review can significantly improve the quality of a scientific paper.
Some reviews focus mainly on editorial corrections or stylistic improvements, which are also valuable. However, the most important reviews are those that ask deep scientific questions and encourage authors to reconsider interpretations, improve methodologies, clarify conclusions, or better explain their results.
Very often, reviewers help authors notice problems or weaknesses that they themselves overlooked. In my own field, for example, I have often observed that methodological descriptions are incomplete or insufficiently precise. Usually, this is not because authors wish to hide anything, but simply because they unintentionally omit details. A reviewer’s task is to identify such issues and ensure that the methods and results are described properly and transparently.
Reviewers also play a major role in maintaining scientific quality standards. Of course, rejecting a paper is never pleasant because authors invest enormous effort into their research, but sometimes rejection is necessary if the work does not meet the required standards of a journal.
Overall, I think peer review is essential because it improves manuscripts, strengthens scientific rigor, and protects publication quality.
5. How do you balance the comprehensiveness and efficiency of review? Can you share some specific methods or principles for reviewing?
One thing I appreciate very much about MDPI journals is the efficiency of the review and publication process. Compared with traditional journals, where publication may take many months or even years, the MDPI system is remarkably fast and efficient.
In my experience, the standard one-week review period is usually sufficient for preparing a solid review. Often, even if one initially thinks more time is needed, the actual detailed review can realistically be completed within a few focused days.
My own reviewing method usually begins with a first reading of the manuscript in order to obtain a general impression of the work—whether it is scientifically interesting, what may be lacking, and what its strengths are. Then I perform a second, much more detailed reading. During this stage, I annotate specific comments, questions, and concerns throughout the manuscript.
I generally structure my reviews by starting with broad overall comments and then moving toward more detailed line-by-line observations. While I do not focus excessively on minor typographical issues, I still point out language or stylistic problems whenever they are relevant.
In the early years of my reviewing activity, I must admit that sometimes my reviews were too brief. However, editorial feedback encouraged me to make them more comprehensive and detailed, and I believe this improved my reviewing approach considerably.
Of course, comprehensive reviewing requires time and careful analysis, but I think efficiency and quality can coexist when the reviewer is organized and focused.
6. In your view, what characteristics typically define a high-quality peer review report? Drawing upon your extensive experience, what specific details or clues do you look for to determine whether a report might have been generated by AI?
A high-quality review should be detailed, constructive, balanced, and scientifically meaningful. It should not simply state whether a paper is good or bad; it should explain clearly why improvements are needed and provide guidance that helps the authors strengthen their work.
The best reviews usually demonstrate that the reviewer has genuinely engaged with the manuscript, considered the methodology carefully, examined the logic of the conclusions, and evaluated the significance of the findings within the broader scientific context.
Regarding artificial intelligence, I know that journals now require reviewers to declare the use of AI tools. Personally, I do not use AI to generate reviews because I believe that doing so would currently be intellectually dishonest, except perhaps for minor grammar or language corrections after the review is completed.
AI can certainly help identify missing details, compare publications, or detect editorial inconsistencies. However, in my opinion, AI is still unable to adequately evaluate the true novelty, importance, or scientific significance of a paper.
One indication that a report may have been generated by AI is when the review sounds overly generic, formulaic, or lacks deep engagement with the specific scientific content of the manuscript. AI-generated reviews may also focus excessively on formal aspects while failing to provide nuanced scientific judgment or field-specific insight.
Human reviewers bring scientific experience, intuition, contextual understanding, and critical judgment that AI still cannot fully reproduce. Of course, AI systems will continue to improve, so this situation may evolve in the future.
7. Please briefly describe your experience with our services and journals so far.
My experience with MDPI journals and services has generally been very positive. I have worked with several MDPI journals, including Nutrients, Foods, Molecules, Processes, and the International Journal of Molecular Sciences.
What I appreciate most is the efficiency of the editorial workflow, proofreading process, and online publication system. In situations where rapid publication was important—for example, for grant applications or PhD defenses—the speed of publication was extremely valuable.
I also think the reviewer recognition system is very good and motivating. The journal communicates efficiently with reviewers and authors, and the editorial offices are generally very supportive.
One aspect I am somewhat more critical about is the very large number of Special Issues organized across MDPI journals. Sometimes researchers receive numerous invitations to contribute to Special Issues. In my opinion, this approach can occasionally feel too aggressive, but I can understand why the journals are using it.
Nevertheless, overall, my experience with the journals and services has been very positive, and I greatly appreciate the professionalism, efficiency, and support provided by the editorial teams.
2 June 2026
Interview with Dr. Constantinos Giaginis—Winner of the Nutrients Outstanding Reviewers Award
- Can you briefly introduce yourself and the main content of your current research?
I am a professor in human nutrition, wellness, and public health at the University of the Aegean in Limnos Island, Greece. My academic background includes studies in chemistry, followed by two PhDs, one in medicinal chemistry and another in human pathophysiology.
My current research mainly focuses on human nutrition and the impact of dietary patterns, particularly the Mediterranean diet, on human health. I am especially interested in the relationship between nutrition and chronic diseases, including cardiovascular diseases and cancer, to support preventive healthcare and public health strategies. - When and how did you first become aware of Nutrients? What attracts you most about this journal?
I became aware of Nutrients several years ago through my academic work in nutrition and public health research. What initially attracted me to the journal was its open-access model, which allows researchers worldwide to access scientific information freely.
Another important aspect was the efficiency of the peer-review and publication process. Nutrients combines a relatively fast editorial process with rigorous scientific standards and high-quality peer review, which I highly appreciate as both an author and a reviewer. - Could you share with us your feelings about winning the award? What does this award mean to your academic career?
Receiving the Outstanding Reviewer Award was a great honour and a very positive experience for me. I have served as a reviewer for scientific journals for approximately twenty years, and this is the first reviewer award I have received. Therefore, I truly appreciate this recognition.
Although such awards may not directly influence academic promotion within my institution or country, the recognition itself is meaningful because it acknowledges the effort, responsibility, and scientific contribution involved in the peer-review process. It also motivates me to continue contributing actively to the scientific community. - What role do you think reviewers play in the process of paper publication?
Reviewers play a fundamental role in scientific publishing. Drawing on their expertise and independent perspective, reviewers critically evaluate manuscripts and identify both strengths and weaknesses in the research.
In my opinion, peer review is not only an evaluation process but also an important scientific contribution. Constructive reviewer comments can significantly improve the scientific quality, clarity, methodology, and interpretation of a manuscript, ultimately strengthening both the publication and the research itself. - How do you balance the comprehensiveness and efficiency of review? Can you share some specific methods or principles for reviewing?
My reviewing process usually follows several structured steps. First, I read the manuscript quickly to obtain a general overview of the study and its objectives. During the second reading, I focus particularly on the introduction to evaluate the novelty and scientific relevance of the research question.
I then carefully examine the methodology section, which I consider one of the most critical parts of any scientific paper. I evaluate whether the methods are appropriate, clearly described, and scientifically valid. I also devote considerable attention to the discussion section, particularly the interpretation of results, the connection to the previous literature, and the presentation of the study’s strengths and limitations.
Additionally, I pay attention to language clarity. I believe scientific writing should remain accessible and understandable to an international audience, including researchers whose native language is not English. - In your view, what characteristics typically define a high-quality peer-review report? Drawing upon your extensive experience, what specific details or clues do you look for to determine whether a report might have been generated by AI?
A high-quality peer-review report should contain clear scientific reasoning, balanced criticism, and constructive recommendations for improvement. Reviewers should evaluate both the strengths and weaknesses of a manuscript and provide practical suggestions that help authors improve the quality of their work.
Regarding AI-generated reviews, certain indicators may suggest the use of artificial intelligence tools. For example, reviews with perfectly polished language and no natural inconsistencies may appear suspicious. More importantly, AI-generated comments often lack deep scientific interpretation and may struggle to logically connect study findings with the previous literature.
In my experience, nuanced scientific discussion, contextual interpretation of results, and discipline-specific critical thinking remain areas where genuine expert evaluation is essential. - Please briefly describe your experience with our services and journals so far?
My overall experience with Nutrients and its editorial services has been very positive, both as an author and as a reviewer. I have submitted several manuscripts to the journal and have also reviewed many papers over the years.
I particularly appreciate the efficiency and organization of the submission and peer-review platform, which I find highly user-friendly compared to many other journals. The structured reviewer forms are also very useful because they guide reviewers systematically through the evaluation process and ensure that all important scientific aspects are addressed.
Overall, my collaboration with the journal has been excellent, and I look forward to continuing this collaboration in the future.
1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

30 Years of Open Science, Built Together
This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.
The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.

Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.
Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.
MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.
While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.
I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.
Thank you for being part of this journey.
Impactful Research

Highlights from MMCS 2026 in Beijing (14-17 May)
From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.
The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.

The scientific program covered seven themes:
- Chemical Biology for Drug Discovery
- Medicinal Chemistry Research Progress
- Natural Products in Drug Discovery
- AI-enabled Drug Discovery
- GPCR & Ion Channel Targeted Drug Development
- Innovative Proximity-Based Drug Modalities
- Biocatalysis for Natural Product & Drug Synthesis
The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.
|
|
|
Thanks to our Sponsors
MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.

30th Anniversary Celebration of Molecules
During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.

Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.
They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.
Inside MDPI

Open Access Policies Continue to Accelerate Globally
One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.
Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.
For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.
“Expectations around openness and compliance continue to accelerate”
Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.
Recent Policy Developments
South Africa
In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”
The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.
Canada
In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.
The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”
Chile
Chile is a collaborative and engaged member of the global open access movement.
The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.
ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.
Openness Beyond Research
At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.
As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.

Thank You
I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.
Coming Together for Science

Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)

On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.
The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.
We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.
MDPI in Spain
Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.
A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:
- 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
- 211,200+ total publications (2021–2025), with 84% published open access.
- 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
- More than115,100 MDPI publications from Spanish institutions since 1996.
- More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
- 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
- Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.
Program Overview
What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:
- MDPI Introduction – Stefan Tochev (CEO).
- Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
- Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
- Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
- A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).
|
|
|
|
|
|
|
|
Panel Discussion
We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.
|
|
|
|
Themes from the Summit
Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:
- The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
- Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
- AI is rapidly changing scholarly communication and requires transparent and responsible governance.
- Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.
“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”
It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.
|
|
|
|
Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.
Thank You
Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.
|
|
|
|
|
|
|
|
As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.
Closing Thoughts

Highlights from Antibiotics 2026 in Barcelona (11–14 May)
This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.
The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.

Scientific Exchange on a Global Challenge
Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:
- Antimicrobial resistance mechanisms
- One Health approaches to antimicrobial stewardship
- Discovery of novel antimicrobial agents
- Innovation in clinical strategies and treatment approaches
- Ethnopharmacology and emerging therapies
Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.
|
|
|
International Participation and Collaboration
One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.
The scientific program included:
- 2 keynote speakers
- 10 invited speakers
- 36 selected talks
- 78 posters
The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.
|
|
|
|
The Role of Conferences in Scholarly Communication
Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.

Thank You
I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.

Chief Executive Officer
MDPI AG
26 May 2026
Interview with Dr. Maria Spanoudaki—Winner of the Nutrients Travel Award
Information about the winner:
Name: Dr. Maria Spanoudaki
Affiliation: International Hellenic University, Greece
- Congratulations on winning the Nutrients Travel Award! What does this recognition mean to you, and how has it impacted your research and professional development? Can you share with us your feelings about winning the award?
Thank you very much, truly from the bottom of my heart. For me, it is a great honor to have won the award, and I feel deeply grateful. This recognition means a lot, especially because it reflects the work and consistency I have dedicated to over the past years. - Where did you learn about how to apply for this journal award? Can you briefly introduce which conference or conferences you plan to attend with this award?
I first came across it on the MDPI website, and I also received information from my supervisor, who encouraged me to apply. I was already familiar with the process, so I was very happy to submit my application.
The award allows me to attend the ESPEN Congress in Berlin, which is a major opportunity. It enhances my visibility within the scientific community and provides a platform to present my research to international experts. - Attending international conferences is an essential part of scientific collaboration and growth. How did the Travel Award support your participation in ESPEN Congress 2026, and how do you plan to promote the journal at the conference? Do you have any thoughts on how the promotion of the journal at conferences could be more effective?
I plan to include the Nutrients logo on all my presentation slides and acknowledge the journal during my talk. I will also promote it through my social media channels. In addition, I intend to share the journal through my academic networks, including Aegean College and the International Hellenic University. I believe these are effective ways to reach a wide audience and increase visibility. - How did you first learn about the journal Nutrients? What were your initial impressions of it?
My journey with MDPI has been extensive and very positive. I have published around 20 articles in MDPI journals, six of them in Nutrients. My experience with Nutrients in particular has been excellent. I feel a strong professional connection with the journal, and receiving this award feels like recognition of my research efforts over the past four years. I especially appreciate the efficiency of the review process—the speed and quality of feedback are very important for researchers.
Initially, the impact factor attracted me to publish in Nutrients, as it is well-recognized globally. However, the most important reason was the scientific content. My research focuses on metabolism, biochemistry, and clinical nutrition, and Nutrients publishes high-quality work in these areas. I had been following the journal for a long time, and it was actually one of my goals to publish there. - What challenges have you encountered in your work, and how did you overcome them?
One of the main challenges has been bridging the gap between mechanistic research and clinical application—translating complex biochemical findings into practical dietary recommendations is not easy. I addressed this by adopting a multidisciplinary approach and collaborating closely with clinicians. My background also helped me manage these challenges. I have about 40 years of clinical experience and previously served as Director of the Clinical Dietetics Department at a military hospital in Thessaloniki. - What trends or developments in nutrition do you find most exciting right now?
I am particularly interested in the gut microbiome and precision nutrition. Moving away from a “one-size-fits-all” approach toward personalized nutrition is very promising, especially for managing chronic diseases and even mental health. I am also interested in metabolism, muscle wasting, sarcopenia, and obesity-related conditions. These are highly relevant and evolving areas in modern nutrition science. - As the winner, you will have an opportunity to publish your work for free in Nutrients. When do you plan to submit it?
Very soon. I am currently finalizing a manuscript from my PhD research and expect to submit it within the next few days. I am very grateful for the opportunity to publish it with the support of this award. Although I have recently retired, I remain very active in research. I am currently completing my PhD and working on new studies, including research on sarcopenia in obese populations. Retirement has actually given me more time to focus on research and writing, which I find very fulfilling.
14 May 2026
Nutrients Webinar | Exploring the Key to Healthy Cardiac Metabolism: Managing Diet, Nutrients, and Lifestyle Choices, 21 May 2026
It is a pleasure to welcome you to this webinar linked to our Special Issue “Nutrition, Lifestyle, and Cardiac Metabolism”.
The growing global burden of cardiovascular disease highlights the urgent need to better understand how dietary patterns and lifestyle behaviors influence cardiac metabolism and overall heart health. Emerging research continues to demonstrate that key nutrients—such as omega–3 fatty acids, antioxidants, and dietary fiber—play a fundamental role in reducing inflammation, improving lipid profiles, and supporting vascular function. At the same time, excessive consumption of processed foods, refined sugars, and saturated fats has been strongly associated with metabolic disorders, including obesity, insulin resistance, and atherosclerosis. Beyond nutrition, lifestyle factors such as physical activity, stress management, sleep quality, and avoidance of smoking and excessive alcohol intake are increasingly recognized as critical modulators of cardiometabolic health.
This webinar aims to explore the complex interplay between nutrition, metabolism, and cardiovascular function. We seek to highlight current advances in research, discuss evidence–based dietary and lifestyle strategies, and identify future directions for improving cardiac health and preventing disease. Key themes will include the role of specific nutrients and dietary patterns, mechanisms linking metabolism to cardiovascular outcomes, and the impact of holistic lifestyle interventions on long–term heart health.
We hope this session will foster meaningful discussion and collaboration, contributing to a deeper understanding of how integrated nutritional and lifestyle approaches can optimize cardiometabolism and support cardiovascular well–being.
Thank you for joining us, and we look forward to an engaging and insightful webinar.
Date: 21 May 2026 | 1:00 p.m. CEST | 7:00 a.m. EDT | 7:00 p.m. CST Asia
Webinar ID: 829 4127 7216
Webinar Website: https://sciforum.net/event/Nutrients–28?subscribe
Register now for free!
Program:
| Speaker/Presentation | Time in CEST | Time in EDT | Time in CST Asia |
| Christina Chrysohoou & Christos Fragoulis Chair Introduction |
1:00–1:05 p.m. | 7:00–7:05 a.m. | 7:00–7:05 p.m. |
| Evangelia Damigou The Role of Diet in the Prevention of Metabolic Syndrome |
1:05–1:20 p.m. | 7:05–7:20 a.m. | 7:05–7:20 p.m. |
| Marilena Giannoudi Diet–Transcriptome Interactions in Cardiometabolic Syndrome: Epigenetic Mechanisms and Clinical Implications |
1:20–1:35 p.m. | 7:20–7:35 a.m. | 7:20–7:35 p.m. |
| Ioana Cristina Daha Psychosocial Interventions in the Improvement of the Cardiometabolic Profile |
1:35–1:50 p.m. | 7:35–7:50 a.m. | 7:35–7:50 p.m. |
| Q&A Session | 1:50–2:00 p.m. | 7:50–8:00 a.m. | 7:50–8:00 p.m. |
| Closing of Webinar | 2:00–2:05 p.m. | 8:00–8:05 a.m. | 8:00–8:05 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.
Webinar Chairs and Keynote Speakers:
- Dr. Christina Chrysohoou, 1st Cardiology Clinic, Hippokration Hospital, National and Kapodistrian University of Athens, Greece;
- Dr. Christos Fragoulis, 1st Cardiology Clinic, Hippokration Hospital, National and Kapodistrian University of Athens, Greece;
- Dr. Evangelia Damigou, Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University of Athens, Greece;
- Dr. Marilena Giannoudi, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK;
- Dr. Ioana Cristina Daha, Cardiology Department, Colentina Clinical Hospital, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Relevant Special Issue:
“Exploring the Key to Healthy Cardiac Metabolism: Managing Diet, Nutrients, and Lifestyle Choices”
Guest Editor: Christina Chrysohoou
Deadline for manuscript submissions: 25 June 2026
6 May 2026
MDPI INSIGHTS: The CEO's Letter #34 - MDPI US Office, Coatings 2026, Media and Partnerships, Recapping Poland Summit & Serbia Salon
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

MDPI Opens First US Office in Philadelphia
I am delighted to highlight an important milestone in MDPI’s continued global development: the recent opening of our first office in the United States, located in Philadelphia.
This marks a significant step in building our engagement with one of the world’s most important research communities. The new office will serve as a hub for supporting scholars across the US, creating closer connections and more localized support.
As highlighted in recent coverage by our press release in InPublishing, this expansion reflects MDPI’s broader commitment to growing our international presence while remaining focused on the needs of the research community.
A Key Market for Research and Collaboration
The United States continues to play a central role in global research. To date, MDPI has published more than 237,000 articles affiliated with US institutions, and we collaborate with nearly 12,000 Editorial Board Members across the country. These relationships are fundamental to our mission of supporting Open Access and advancing scientific communication.
The opening of this office is not just about geography; it is about proximity to the communities we serve. It allows us to better understand the evolving needs of researchers while continuing to build collaboration and trust within the academic ecosystem.
The Team Behind this Milestone

This milestone reflects the efforts of teams across MDPI. I extend a special thank-you to Bob Vrooman (Head of Business Development, MDPI), who is leading this expansion, as well as to our colleagues in Toronto and across our North American teams for their continued support.
Bob shared: “MDPI is already a trusted partner of the North American research community, due in no small part to our dedicated team in Canada. Launching our first US office in Philadelphia is a great first step towards expanding MDPI’s market share and recognition in the US. I’m thrilled to be a part of this new phase in MDPI’s journey.”
As we continue to grow, our focus remains on supporting researchers globally and advancing Open Access with integrity.
Impactful Research

Coatings 2026: Highlights from Our Latest MDPI Conference (20-22 April)
I am pleased to share the successful completion of MDPI conference Coatings 2026, which took place last week in Athens from 20 to 22 April 2026. This conference brought together a diverse international community of researchers, industry experts, and partners, highlighting MDPI’s role not only as a publisher but also as a platform for scientific exchange and collaboration.
Conference Highlights
Coatings 2026 in numbers:
- The event attracted approximately 140 participants from 25 countries
- 143 submissions and a strong scientific program of talks and posters
- 2 keynote speakers and a wide range of invited contributions
- 7 sponsors and 11 media partners supporting the event
|
|
|
|
|
|
Scientific Programme
The program centered on “Safe and Sustainable by Design,” reflecting the growing importance of sustainability, regulatory frameworks, and technological innovation in materials science. Topics ranged from advanced coating technologies and additive manufacturing to AI-driven simulations and strategies to phase out potentially harmful substances in industrial processes.
Importantly, the conference brought together both academic and industrial perspectives, creating a space for dialogue on how research can translate into real-world impact. This is important as industries navigate environmental challenges, evolving regulations, and the need for more sustainable and circular approaches to production.
Thank You!
I would like to thank the entire conference team for their work in organizing this successful event. As we continue to grow, conferences like this play an important role in building our connection with global research communities, supporting interdisciplinary collaboration, and positioning MDPI at the intersection of science, technology, and societal impact.
Members from Exelisis and MDPI EU Conference & Social Media team at the Coatings 2026 Conference in Athens, Greece.
Inside MDPI

Recent Media Coverage and Partnerships
Over the past two months, news from MDPI has enjoyed strong visibility across international publishing and academic media, reflecting our continued expansion and the increasing relevance of our work within the research community.
Below are some highlights covering partnerships, institutional agreements, and milestones that continue to shape our position in publishing – some of which are featured in leading industry platforms such as InPublishing, which is highly selective and reflects the growing recognition of MDPI’s growth within the publishing ecosystem.
Key Press Releases & Coverage (March–April 2026)
-
MDPI × Sikt (Norway): Partnership Renewal
We renewed our national Open Access agreement with Sikt, a key consortium partnership, continuing to support researchers across Norway through this partnership. The renewal was covered by several international publishing trade outlets.
Covered by: Research Information, STM Publishing News, ALPSP, Europe Says
-
MDPI × Jisc (UK): New Two-Year Open Access Agreement
A new two-year agreement with Jisc significantly expands MDPI’s footprint across UK academic institutions. Coverage appeared across major publishing industry titles in the UK and internationally.
Covered by: InPublishing, Research Information, STM Publishing News, ALPSP
-
MDPI Opens First US Office
The opening of our first US office marks an important milestone in our North American expansion to build engagement with one of the world’s leading research communities.
Coverage by: EurekAlert!, InPublishing, EdTech Innovation Hub, STM Publishing News, ALPSP
-
MDPI × SIGG: Italian Society of Gerontology and Geriatrics
We established a new partnership with the Italian Society of Gerontology and Geriatrics (SIGG), adding to our growing portfolio of society collaborations.
Coverage by: EurekAlert!, STM Publishing News, ALPSP
-
MDPI × Fast Track Health: New Journal Launch
The launch of a new journal in partnership with Fast Track Health reflects our continued expansion into emerging areas of health innovation.
Coverage by: EurekAlert!, Scienmag, STM Publishing News, ALPSP
-
MDPI 2025 Annual Report
Our 2025 Annual Report was also widely covered across international media, highlighting a 12% increase in submissions and continued investment in research integrity, infrastructure, and partnerships.
Coverage by: EurekAlert!, Research Information, STM Publishing News, ALPSP, Choice 360
Coverage also spanned multiple regions including Poland, Romania and South Korea, reflecting our ongoing efforts to communicate more effectively with regional research communities.
Looking Ahead
This coverage shows that MDPI is growing and building on its position through partnerships, visibility, and engagement across regions. As we continue to expand, our focus remains on supporting researchers globally, building on our institutional collaborations, and advancing Open Access with integrity.
Thank you to all teams involved in delivering these initiatives, and to our External Affairs team for ensuring our work is effectively communicated across the global publishing landscape!
Coming Together for Science

Recapping MDPI Poland Summit 2026 in Krakow (23 April)
On 23 April 2206, we hosted the first MDPI Poland Summit 2026 in Kraków, bringing together an engaged group of editors, researchers, and academic leaders from the country.
The Poland Summit welcomed some 45 participants, including Editors-in-Chief, Associate Editors, and Editorial Board Members, many with strong academic track records and international recognition.
Our engagements were open and constructive, focusing on MDPI’s positioning and reputation in Poland, alongside community interest in supporting our development, with active participation across our sessions, including Q&A and panel discussions.
|
|
|
|
MDPI Poland Summit Programme
From research integrity and peer review quality to AI in publishing and the future of academic communication, the agenda featured important topics currently shaping our industry.
During the day, MDPI colleagues shared a series of presentations covering:
- MDPI’s performance, growth, and impact in Poland: Stefan Tochev (CEO)
- Engagement with Academic Community: Dr. Marta Colomer (Public Affairs Lead)
- Research Integrity and Publication Ethics: Anna Pena (Research Integrity Manager)
- MDPI Editorial Process and Peer-Review Quality Metrics: Dr. Liliane Auwerter (Conference Organizer)
- AI in the Publishing Industry – Challenges, Innovation and MDPI’s vision: Dr. Enric Sayas (AI Product Owner)
- Panel Session: The Future of Academic Publishing, moderated by Dr. Marta Colomer
|
|
|
|
|
|
|
|
Poland as a Key Market for Open Access
The summit also highlighted the importance of Poland within the global research landscape.
In 2025:
- 75% of publications in Poland were made in Open Access
- 71% of those in Gold Open Access
- and over 344,000 publications produced in the last five years
MDPI plays a significant role in the Polish publishing ecosystem:
- #1 Open Access publisher in Poland
- 17% share of Open Access publications in 2025
- More than 12,500 publications from Polish institutions in 2025
- More than 91,000 publications overall since 1996
Looking Ahead
Events like the Poland Summit are an important part of how we evolve as an organization. They allow us to share the latest developments of MDPI and listen directly to our researchers and editors to better understand the market and align our development with the needs of the local community.
As MDPI continues to grow, this type of engagement will remain essential in ensuring that we are not only scaling globally, but doing so in a way that is aligned, trusted, and collaborative.

With Igor Matic (Office Manager, Krakow, Poland, MDPI) at the MDPI Poland Summit in Krakow.
Closing Thoughts

Recapping MDPI Serbia Salon 2026 in Belgrade (22 April)
On 22 April 2026, we hosted the MDPI Serbia Salon 2026 in Belgrade. The Salon welcomed over 50 participants, including more than 40 invited scholars from leading Serbian institutions, alongside colleagues from MDPI. The event also marked two important milestones: 30 years of MDPI and 10 years of our presence in Serbia, making it a celebration and an opportunity for reflection.

A Platform for Exchange
The Salon was designed not just as a series of presentations, but as a place for dialogue. Throughout the day, discussions focused on important topics around publishing today: research integrity and editorial standards, journal indexing and visibility, the evolving role of artificial intelligence, and funding and support for Open Access publishing.
|
|
|
|
|
|
|
|
Program Overview
- Opening the Salon MDPI Serbia 2026 – Serbia results and direction: Emir Ramadani (Operations Manager)
- Update on MDPI’s performance and growth: Stefan Tochev (CEO)
- Collaboration with MDPI – A personal perspective: Prof. Dr Srećko Stopić (Editorial Board Member)
- Linking Scientific Quality and Visibility: The role of indexing in publishing
- Research integrity and editorial ethics: Ana Stanković (Research Integrity Specialist)
- Artificial Intelligence in Scientific Publishing – Challenges, innovations and vision of MDPI: Dr Miloš Čučulović (Head of Technology Innovation)
It was encouraging to see the high level of engagement and discussion with the local academic community.
|
|
|
|
|
|
|
|
Publishing in Serbia
With 10 years of MDPI in Serbia (since 2016) and over 620 colleagues across 10 departments spread across offices in Belgrade and Novi Sad, MDPI continues to invest in the long-term development of the research community in Serbia and beyond.
Some high-level indicators illustrate both the strength of the local research ecosystem and MDPI’s role within it:
- 12,910 total publications in Serbia in 2025, of which 8,708 (67%) were Open Access (of which, in turn, 75% were Gold OA)
- A total of more than 55,000 publications (2021–2025), with 68% published Open Access
- 2,122 MDPI publications from Serbian institutions in 2025
- 25% of all Open Access publications in Serbia are published with MDPI
- More than 11,000 MDPI publications from Serbian institutions since 1996
- More than 75 Editorial Board Members from Serbia, including Editors-in-Chief and Associate Editors.
These figures reflect the growth of OA publishing in Serbia and the strong collaboration between MDPI and Serbia's research community.
Top 5 Publishers in Serbia (MDPI #1 with steady growth)

Looking Ahead
Research integrity and artificial intelligence will remain central topics for the industry. At the same time, clear communication of editorial processes will be essential in building trust and transparency.
Workshops and direct engagement remain among the most effective ways to strengthen these connections. As Open Access funding models continue to evolve, new opportunities for collaboration are emerging across institutions, publishers, and the broader research community.
Thank You!
The excellent feedback from participants shows the value of creating spaces where ideas can be exchanged openly and constructively. Sincere thanks to everyone who contributed to the success of this event: our speakers, participants, and especially the MDPI Serbia team for their great organization and support.

Chief Executive Officer
MDPI AG
30 April 2026
Welcoming New Early Career Editorial Board Members of Nutrients
Nutrients (ISSN: 2072-6643) is pleased to announce the addition of the following researchers to the journal’s Early Career Editorial Board. We would like to congratulate them on becoming part of the Nutrients community!
|
|
Name: Rosario Alonso-Domínguez |
|
|
Name: Grzegorz Kalisz |
|
|
Name: Md Soriful Islam |
|
|
Name: Baptiste Panthu |
|
|
Name: Lorena A. Filip |
|
|
Name: Alberto Romano |
|
|
Name: Matina Kouvari |
|
|
Name: Gloria Domínguez-Rodríguez |
|
|
Name: Catherine Cohen |
|
|
Name: Cristina Tejera Pérez |
|
|
Name: Valentina De Cosmi |
|
|
Name: Stefano Mancin |
|
|
Name: Frank Po Wen Lo |
|
|
Name: Qi Su |
|
|
Name: Amelia Caretto |
|
|
Name: Vilma Kriaucioniene |
|
|
Name: Canxia He |
|
|
Name: Haoran Chen |
|
|
Name: Dianzhi Hou |
|
|
Name: Miguel Rebollo-Hernanz |
|
|
Name: Caterina Carollo |
|
|
Name: Oussama Saidi |
|
|
Name: Camilla Morresi |
|
|
Name: Liangkai Chen |
|
|
Name: Elisavet Moutzouri |
|
|
Name: Lindsay M. Reynolds |
|
|
Name: Annamaria Altomare |
|
|
Name: Roberto Castiglione |
|
|
Name: Marlene Fabiola Escobedo-Monge |
|
|
Name: Marco Crocco |
|
|
Name: Marilyn Nehls |
|
|
Name: Alessandro Leone |
|
|
Name: Pinakin Gunvant Davey |
|
|
Name: Eva Szabo |
|
|
Name: Adil El Midaoui |
|
|
Name: Ildefonso Rodríguez-Ramiro |
|
|
Name: Ana Valente |
|
|
Name: Davide Grassi |
|
|
Name: Dalia El Khoury |
|
|
Name: Wai-Yin Cheng |
|
|
Name: Gianmarco Sabiu |
|
|
Name: Zsolt Gáll |
|
|
Name: Camila Sakaguchi |
|
|
Name: Yoshinori Katakura |
|
|
Name: Tianming Yao |
|
|
Name: Karolina Chilicka-Hebel |
|
|
Name: Hammad Ullah |
|
|
Name: Vassilis Athanasiadis |
|
|
Name: Giuseppe Carota |
|
|
Name: Sebastiano Giallongo |
|
|
Name: Henry H. Ruiz |
|
|
Name: Farid Khallouki |
|
|
Name: Anna Cieslinska |
|
|
Name: Panagiotis Christopoulos |
|
|
Name: Alessio Ardizzone |
|
|
Name: Catarina Rendeiro |
|
|
Name: Hye-jin Yoo |
|
|
Name: Tina Cao |
|
|
Name: Charalampia Amerikanou |
|
|
Name: Sofia Marques Ramalho |
|
|
Name: Serdar H. Ural |
|
|
Name: Ana Stupin |
|
|
Name: Hong Yong Peh |
|
|
Name: Taskeen Niaz |
|
|
Name: Alessia Mariano |
|
|
Name: Ewelina Dziedzic |
|
|
Name: Evangelia Damigou |
|
|
Name: Francesca Latino |
27 April 2026
Meet Us at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026), 28 September–2 October 2026, Milan, Italy
Conference: The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026)
Organization: European Association for the Study of Diabetes
Date: 28 September–2 October 2026
Place: Allianz MiCo—Milan Convention Centre, Milan, Italy
Booth Number: L.03
The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy. This global diabetes conference will convene thousands of delegates from all across the globe to explore the latest advancements in diabetes research, treatment, and care.
The scientific programme will feature hundreds of presentations, including keynote lectures, symposia, and oral sessions, offering insights into cutting-edge developments in both basic and clinical diabetes research. Attendees will have the opportunity to engage with leading experts, fostering collaboration and knowledge exchange across the international diabetes community.
The Organization of this conference, the European Association for the Study of Diabetes e.V. (EASD), is a membership-based academic non-profit organization. It was founded in 1965 and is based in Düsseldorf, Germany. The aims of EASD are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application.
The following open access journals will be represented:
- Biomedicines;
- Diabetology;
- JCM;
- Medicina;
- Endocrines;
- IJERPH;
- Antioxidants;
- Biomolecules;
- Epidemiologia;
- JMAHP;
- Nutrients;
- Trends in Public Health.
If you are attending the 62nd EASD Annual Meeting, we invite you to visit us at our booth #L.03. Our representatives will be available to discuss publishing opportunities, the benefits of open access, and answer any questions that you may have.
Join us in Milan to discover what is next in diabetes science and care! For more information about the conference, please visit its official website at https://www.easd.org/annual-meeting/easd-2026/.















































































































